nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ALB—focal segmental glomerulosclerosis	0.487	1	CbGaD
Enzalutamide—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0894	0.196	CbGbCtD
Enzalutamide—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.086	0.189	CbGbCtD
Enzalutamide—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0721	0.158	CbGbCtD
Enzalutamide—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.06	0.132	CbGbCtD
Enzalutamide—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0582	0.128	CbGbCtD
Enzalutamide—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0548	0.12	CbGbCtD
Enzalutamide—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0349	0.0766	CbGbCtD
Enzalutamide—Hallucination, visual—Cyclosporine—focal segmental glomerulosclerosis	0.00735	0.129	CcSEcCtD
Enzalutamide—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.0577	CcSEcCtD
Enzalutamide—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.0577	CcSEcCtD
Enzalutamide—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.0387	CcSEcCtD
Enzalutamide—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00214	0.0374	CcSEcCtD
Enzalutamide—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.0291	CcSEcCtD
Enzalutamide—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.0265	CcSEcCtD
Enzalutamide—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.026	CcSEcCtD
Enzalutamide—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.0258	CcSEcCtD
Enzalutamide—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0223	CcSEcCtD
Enzalutamide—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.0215	CcSEcCtD
Enzalutamide—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.0202	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.0196	CcSEcCtD
Enzalutamide—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0194	CcSEcCtD
Enzalutamide—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.0189	CcSEcCtD
Enzalutamide—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0188	CcSEcCtD
Enzalutamide—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0188	CcSEcCtD
Enzalutamide—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0179	CcSEcCtD
Enzalutamide—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0177	CcSEcCtD
Enzalutamide—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0176	CcSEcCtD
Enzalutamide—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000966	0.0169	CcSEcCtD
Enzalutamide—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000959	0.0168	CcSEcCtD
Enzalutamide—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000956	0.0167	CcSEcCtD
Enzalutamide—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000952	0.0166	CcSEcCtD
Enzalutamide—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000947	0.0166	CcSEcCtD
Enzalutamide—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000945	0.0165	CcSEcCtD
Enzalutamide—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000874	0.0153	CcSEcCtD
Enzalutamide—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000844	0.0148	CcSEcCtD
Enzalutamide—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000754	0.0132	CcSEcCtD
Enzalutamide—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000751	0.0131	CcSEcCtD
Enzalutamide—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000727	0.0127	CcSEcCtD
Enzalutamide—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000724	0.0127	CcSEcCtD
Enzalutamide—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000714	0.0125	CcSEcCtD
Enzalutamide—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000712	0.0124	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000709	0.0124	CcSEcCtD
Enzalutamide—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00068	0.0119	CcSEcCtD
Enzalutamide—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000671	0.0117	CcSEcCtD
Enzalutamide—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00067	0.0117	CcSEcCtD
Enzalutamide—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000665	0.0116	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000624	0.0109	CcSEcCtD
Enzalutamide—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000619	0.0108	CcSEcCtD
Enzalutamide—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000615	0.0107	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000591	0.0103	CcSEcCtD
Enzalutamide—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00059	0.0103	CcSEcCtD
Enzalutamide—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000491	0.00859	CcSEcCtD
Enzalutamide—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000484	0.00847	CcSEcCtD
Enzalutamide—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000468	0.00819	CcSEcCtD
Enzalutamide—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000453	0.00791	CcSEcCtD
Enzalutamide—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000429	0.0075	CcSEcCtD
